Esperion Therapeutics reported $290.82M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Amarin AMRN:US $ 772.62M 106.11M
Amgen AMGN:US $ 18520M 865M
Biogen BIIB:US $ 7915.9M 59.4M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Cytokinetics CYTK:US $ 623.53M 87.85M
Daiichi Sankyo 4568:JP Y 1345271M 34628M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Esperion Therapeutics ESPR:US $ 290.82M 38.15M
Geron GERN:US $ 175.92M 11.28M
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Intercept Pharmaceuticals ICPT:US $ 477.35M 24.94M
Intra Cellular Therapies ITCI:US $ 848.34M 381.06M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Merk MRK:US $ 31184M 918M
Minerva Neurosciences NERV:US $ 55.7M 6.5M
Moderna Inc MRNA:US 16.35B 279M
Nektar Therapeutics NKTR:US $ 795.58M 190.55M
Ptc Therapeutics PTCT:US $ 774.01M 180.36M
Puma Biotechnology PBYI:US $ 117.57M 22.45M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Seattle Genetics SGEN:US $ 2771.26M 97.94M
United Therapeutics UTHR:US $ 2586.6M 263M
Vanda Pharmaceuticals VNDA:US $ 492.27M 13.97M